News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
86,934 Results
Type
Article (6789)
Company Profile (6)
Press Release (80138)
Multimedia
Podcasts (2)
Webinars (3)
Section
Business (24370)
Career Advice (393)
Deals (3210)
Drug Delivery (10)
Drug Development (8064)
Employer Resources (42)
FDA (2669)
Job Trends (1757)
News (35672)
Policy (3141)
Tag
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
Academia (517)
Accelerated approval (9)
ADA (3)
Adcomms (4)
Allergies (22)
Alliances (6465)
ALS (29)
Alzheimer's disease (760)
Antibody-drug conjugate (ADC) (54)
Approvals (2773)
Artificial intelligence (267)
ASCO (33)
Autoimmune disease (28)
Automation (18)
Bankruptcy (36)
Belgium (7)
Best Places to Work (1542)
BIO (4)
Biologics (17)
Biosimilars (21)
BioSpace Insights (21)
Biotechnology (7)
Bispecific (4)
Bladder cancer (25)
Brain cancer (22)
Breast cancer (189)
Cancer (1022)
Cardiovascular disease (74)
Career advice (343)
Career pathing (2)
CAR-T (22)
CDC (2)
CDMO (26)
Cell therapy (87)
Cervical cancer (6)
Clinical research (6832)
Collaboration (372)
Commercialization (7)
Compensation (21)
Complete response letters (11)
COVID-19 (469)
CRISPR (6)
CRO (1)
C-suite (172)
Cystic fibrosis (9)
Data (1316)
Decentralized trials (2)
Depression (17)
Dermatology (14)
Diabetes (54)
Diagnostics (1631)
Digital health (13)
Diversity (2)
Diversity, equity & inclusion (11)
Drug discovery (49)
Drug pricing (6)
Duchenne muscular dystrophy (35)
Earnings (7709)
Editorial (8)
Employer branding (6)
Employer resources (41)
ESMO (32)
Events (10627)
Executive appointments (133)
Eye disease (4)
FDA (3336)
Fibrodysplasia Ossificans Progressiva (1)
Fragile X (1)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (229)
Gene editing (11)
Generative AI (18)
Gene therapy (67)
GLP-1 (125)
Government (523)
Guidances (48)
Healthcare (2730)
Hematology (11)
HIV (5)
Huntington's disease (6)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (13)
Immunology and inflammation (19)
Immuno-oncology (8)
Indications (40)
Infectious disease (492)
Inflammatory bowel disease (29)
Inflation Reduction Act (1)
Influenza (11)
Intellectual property (41)
Interviews (80)
IPO (1172)
IRA (2)
Job creations (237)
Job search strategy (269)
JPM (6)
Kidney cancer (8)
Kidney disease (13)
Labor market (3)
Layoffs (70)
Leadership (9)
Legal (500)
Licensing (9)
Liver cancer (22)
Longevity (7)
Lung cancer (127)
Lymphoma (34)
Machine learning (13)
Management (15)
Manufacturing (124)
Marketing (4)
MASH (33)
Medical affairs (2)
Medical device (2744)
Medtech (2793)
Mergers & acquisitions (2168)
Metabolic disorders (142)
mRNA (34)
Multiple sclerosis (72)
NASH (6)
Netherlands (6)
Neurodegenerative disease (128)
Neuropsychiatric disorders (11)
Neuroscience (1069)
Neurotech (3)
NextGen: Class of 2026 (750)
Non-profit (579)
Now hiring (6)
Obesity (52)
Opinion (48)
Ovarian cancer (19)
Pain (35)
Pancreatic cancer (43)
Parkinson's disease (100)
Partnered (11)
Patents (93)
Patient advocacy (2)
Patient recruitment (92)
Patient selection (10)
Peanut (3)
People (7452)
Peptides (3)
Pharmaceutical (1)
Pharmacy benefit managers (1)
Phase 1 (1879)
Phase 2 (3055)
Phase 3 (2638)
Pipeline (1740)
Policy (18)
Postmarket research (204)
Preclinical (804)
Press Release (6)
Prostate cancer (125)
Radiopharmaceuticals (232)
Rare diseases (99)
Real estate (635)
Recruiting (18)
Regenerative medicine (6)
Regulatory (2924)
Reports (8)
Research institute (433)
Resumes & cover letters (57)
Rett syndrome (4)
RNA editing (4)
RSV (1)
Schizophrenia (19)
Series A (35)
Series B (19)
Sickle cell disease (8)
Special edition (1)
Spinal muscular atrophy (30)
Sponsored (20)
Startups (377)
Stomach cancer (3)
Substance use disorders (1)
Supply chain (10)
Switzerland (3)
Tariffs (1)
The Weekly (2)
Vaccines (180)
Venture capital (10)
Weight loss (22)
Wet AMD (1)
Women's health (28)
Worklife (7)
Date
Today (1)
Last 7 days (96)
Last 30 days (352)
Last 365 days (3350)
2026 (2945)
2025 (3116)
2024 (4129)
2023 (5003)
2022 (8737)
2021 (7452)
2020 (6077)
2019 (5867)
2018 (4400)
2017 (3873)
2016 (3822)
2015 (4383)
2014 (3310)
2013 (2863)
2012 (3015)
2011 (3207)
2010 (2800)
Location
Africa (103)
Alabama (3)
Alaska (1)
Arizona (73)
Arkansas (5)
Asia (5204)
Australia (1051)
California (1375)
Canada (429)
China (97)
Colorado (70)
Connecticut (54)
Delaware (50)
Europe (12109)
Florida (404)
Georgia (66)
Hawaii (1)
Idaho (12)
Illinois (254)
India (11)
Indiana (110)
Iowa (4)
Japan (117)
Kansas (13)
Kentucky (6)
Louisiana (7)
Maine (14)
Maryland (110)
Massachusetts (1163)
Michigan (67)
Minnesota (103)
Mississippi (2)
Missouri (19)
Nebraska (3)
Nevada (17)
New Hampshire (23)
New Jersey (367)
New Mexico (10)
New York (462)
North Carolina (169)
North Dakota (1)
Northern California (664)
Ohio (32)
Oklahoma (2)
Oregon (10)
Pennsylvania (220)
Rhode Island (6)
South America (169)
South Carolina (31)
Southern California (589)
Tennessee (34)
Texas (463)
United States (5792)
Utah (58)
Vermont (1)
Virginia (29)
Washington D.C. (5)
Washington State (87)
West Virginia (3)
Wisconsin (32)
86,934 Results for "aspect imaging".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
AstraZeneca Builds Obesity Pipeline On ‘Medical Aspect,’ Not Aesthetics
In an investor call Thursday, AstraZeneca CEO Pascal Soriot outlined his company’s approach to obesity drug development based on “the medical aspect” of weight loss, including driving down visceral fat.
November 6, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Annexon to Host Virtual Investor Event on November 3, 2026: Vonaprument for the Treatment of Geographic Atrophy - Highlighting Key Aspects of Phase 3 ARCHER II Trial
October 28, 2026
·
2 min read
Press Releases
Voiant Expands Clinical Trial Imaging Services into Obesity and Metabolic Disease Research
Highlight: Voiant expands into obesity and metabolic disease research, helping sponsors move beyond traditional weight-loss measures with advanced body composition and metabolic imaging endpoints.
August 4, 2026
·
1 min read
Press Releases
QT Imaging Announces CPT® Category III Code for 3D Breast Acoustic Imaging Now Effective
October 1, 2026
·
5 min read
Press Releases
QT Imaging Appoints Imaging Industry Veteran Dr. Mark Winkler as Chief Medical Officer
September 17, 2026
·
8 min read
Press Releases
Lumexa Imaging Announces Third Quarter 2026 Earnings Conference Call Date
October 28, 2026
·
1 min read
Press Releases
Advanced Imaging Uncovers Genomic Achilles’ Heel That Makes Cancer Cells Vulnerable to Treatment
November 5, 2026
·
6 min read
Press Releases
Conavi Medical to Showcase FDA-Cleared Hybrid Imaging System at TCT 2026
October 15, 2026
·
6 min read
Press Releases
Aspect Biosystems Announces $280 Million Partnership with Government of Canada to Advance Development of Bioengineered Cellular Medicines
April 3, 2026
·
3 min read
Press Releases
Philips launches UniGuide 3D Live Guidance, bringing CT planning into live procedures and extending the capabilities of its Azurion image-guided therapy platform
October 29, 2026
·
6 min read
1 of 8,694
Next
